Project Grant HT94252410895
Award Date
8/15/24
Completion Date
8/14/25
Dollars Obligated
$160K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Chicago, IL 60612, USA
Similar Awards
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $158,254 to the University of Illinois to support research on a "DUAL CRE/LOX AND LENTIVIRAL CRISPR/CAS9 SYSTEM FOR PRECISE IN VIVO DISSECTION OF GBM AND MICROENVIRONMENT INTERACTION". The award, with a performance period from Aug 15, 2024 to Aug 14, 2026, will fund innovative biomedical research to advance treatments for glioblastoma, a...
The Defense Health Agency awarded a $159,892 Project Grant to the University of Illinois under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant supports research into "Metabolic Vulnerabilities Associated to G12C Inhibitor Resistance" from January 1, 2022 through December 31, 2023. The Military Medical Research and Development program aims to transform military and public health through innovative medical research solutions. This award...
The U.S. Department of Defense's Defense Health Agency has awarded a $1,599,997 Project Grant to the University of Illinois under the Military Medical Research and Development program (CFDA 12.420) to conduct a clinical trial for multiple sclerosis research. The award, which began on September 1, 2024, will support the university's efforts to investigate innovative treatments and advance scientific knowledge related to this neurological disorder over the next 3 years, with a planned...
This federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $1,602,572.00 in funding to the University of Illinois to support research on the role of the novel hexokinase HKDC1 in hepatocellular carcinoma. The award has a performance period from July 15, 2024 to July 14, 2027. The University of Illinois, a major public research university in Chicago, will conduct innovative scientific studies to advance...
The University of Illinois was awarded a $719,550 Project Grant from the Defense Health Agency under the CFDA Program 12.420 - Military Medical Research and Development. The grant, with an April 1, 2024 award date and March 31, 2027 completion date, will support research on the TRKA-MLK3 axis as an actionable target in triple-negative breast cancer. The project aims to advance scientific understanding and develop new treatments related to this specific type of breast cancer, which is a key...
This $293,978 Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), supports research at the University of Illinois to investigate the relationship between cognition, vascular function, and physical activity in multiple sclerosis. The research project will be conducted from November 1, 2024 to October 31, 2026. This federal grant funding will enable the University of Illinois to advance scientific understanding and...
The University of Illinois was awarded a $1,499,728 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on July 1, 2023, will fund research to investigate a novel approach to reverse volumetric muscle loss following transfemoral amputations, with the goal of improving mobility and function. The research aims to transform health care for service members and the American public through innovative biomedical...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $799,496 project grant to the University of Illinois to conduct the research project "Environmental Disruption of Metabolism: Neurocognitive Consequences a Therapeutic Intervention". The award period runs from September 30, 2023 to September 29, 2025. The objective of this research is to investigate the neurocognitive impacts of environmental disruptions to metabolism and...
The Defense Health Agency awarded a $1,398,689 Project Grant to the University of Illinois under the Military Medical Research and Development program (CFDA 12.420) to support research on "Pharmacologic Downregulation of SOX2 to Enhance Efficacy of Anti-AR Therapies in Prostate Cancer". The project aims to investigate methods for improving the effectiveness of anti-androgen therapies for prostate cancer through modulating the SOX2 protein. The award will fund this 3-year research...
This federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) provides $1,119,113.00 to the University of Illinois to explore metabolic vulnerabilities in KRAS G12C inhibitor resistance. The funding will support a 2-year research project from July 1, 2023 to June 30, 2025, investigating new approaches to overcoming drug resistance in cancer treatment. As a major research university, the University of Illinois has extensive...